Faculty Opinions recommendation of SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.
Toyohara T, Suzuki T, Morimoto R +28 more2009J AM Soc Nephrol
CardiovascularImmune/InnateRenal
Summary
No abstract is available for this paper. It was published in J AM Soc Nephrol in 2009 by Toyohara T and colleagues. CIRS Nexus tags it under Cardiovascular, Immune/Innate, Renal. The DOI and PubMed links above lead to the full record.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Childhood Obesity: Insight into Kidney InvolvementInternational Journal of Molecular Sciences · 2023 · 3 shared tags
- Modulation of Sirt1 and FoxO1 on Hypothalamic Leptin‐Mediated Sympathetic Activation and Inflammation in Diet‐Induced Obese RatsJournal of the American Heart Association · 2021 · 3 shared tags
- Review: Shilajit (Mumie) A natural Product with Anti-hyperglycemic, Anti-obesity, Anti-oxidant, and Anti-Inflammatory properties for a potential treatment of diabetes mellitusJordan Journal of Biological Sciences · 2024 · 3 shared tags
- Mechanisms and pharmacotherapy of cancer cachexia‐associated anorexiaPharmacology Research & Perspectives · 2025 · 3 shared tags
- Rett syndrome: think outside the (skull) boxFaculty Reviews · 2021 · 3 shared tags
- Chronic Diarrhea and Weight Loss in an 18-month-old BoyPediatrics in Review · 2021 · 3 shared tags